Abstract
Recent research suggests an association between the development and progression of chronic kidney disease (CKD) - which affects 10–13% of the general population and leads to high rates of morbidity - and sleep apnea (SA).
SA impacts 2–4% of middle aged adults through one of its three forms: obstructive (OSA), central (CSA) and mixed sleep apnea, respectively. SA is associated with sleep fragmentation and hypoxemia during the apneic phenomena. Sleep fragmentation activates the renin-angiotensin-aldosterone system and the sympathetic nervous system, and alters the cardiovascular hemodynamic. It also results in the production of free radicals. SA is a risk factor for CKD progression because it is associated with glomerular hyper-filtration and may be an independent predictor of proteinuria. More specifically, the treatment of sleep apnea, manifested through one of its three forms - obstructive, central, and mixed, respectively - can reduce the severity of CKD and delay its progression by reducing CKD risk factors.
This paper discusses the mechanisms that link CKD and sleep apnea, and suggests SA treatments with beneficial effects to CKD-related cases. Optimizing sleep duration and quality and treating sleep disorders, especially SA, we can reduce the severity of CKD and the delay of progression.
Keywords: Sleep apnea, Hypertension, Renin-angiotensin-aldosterone system, Autonomic nervous system, Chronic kidney disease.
Current Respiratory Medicine Reviews
Title:The Links Between Sleep Apnea and Chronic Kidney Disease
Volume: 11 Issue: 4
Author(s): Marius Balint Gib, Christophe Aron, Svetlana Ilie, Frederic Wallyn, Macha Tetart and Dumitrita Balint Gib
Affiliation:
Keywords: Sleep apnea, Hypertension, Renin-angiotensin-aldosterone system, Autonomic nervous system, Chronic kidney disease.
Abstract: Recent research suggests an association between the development and progression of chronic kidney disease (CKD) - which affects 10–13% of the general population and leads to high rates of morbidity - and sleep apnea (SA).
SA impacts 2–4% of middle aged adults through one of its three forms: obstructive (OSA), central (CSA) and mixed sleep apnea, respectively. SA is associated with sleep fragmentation and hypoxemia during the apneic phenomena. Sleep fragmentation activates the renin-angiotensin-aldosterone system and the sympathetic nervous system, and alters the cardiovascular hemodynamic. It also results in the production of free radicals. SA is a risk factor for CKD progression because it is associated with glomerular hyper-filtration and may be an independent predictor of proteinuria. More specifically, the treatment of sleep apnea, manifested through one of its three forms - obstructive, central, and mixed, respectively - can reduce the severity of CKD and delay its progression by reducing CKD risk factors.
This paper discusses the mechanisms that link CKD and sleep apnea, and suggests SA treatments with beneficial effects to CKD-related cases. Optimizing sleep duration and quality and treating sleep disorders, especially SA, we can reduce the severity of CKD and the delay of progression.
Export Options
About this article
Cite this article as:
Gib Balint Marius, Aron Christophe, Ilie Svetlana, Wallyn Frederic, Tetart Macha and Balint Gib Dumitrita, The Links Between Sleep Apnea and Chronic Kidney Disease, Current Respiratory Medicine Reviews 2015; 11 (4) . https://dx.doi.org/10.2174/1573398X11666150915213824
DOI https://dx.doi.org/10.2174/1573398X11666150915213824 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Era: Mavacamten for Obstructive Hypertrophic Cardiomyopathy
Cardiovascular & Hematological Agents in Medicinal Chemistry MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Current Medicinal Chemistry Advances in Therapy for Psoriasis: An Overview of Infliximab, Etanercept, Efalizumab, Alefacept, Adalimumab, Tazarotene, and Pimecrolimus
Current Pharmaceutical Design Experimental Animal Models of Myocardial Damage in Regenerative Medicine Studies Involving Adult Bone Marrow Derived Stem Cells: Ethical and Methodological Implications
Cardiovascular & Hematological Disorders-Drug Targets Clinical Development of Cell Therapies to Halt Lysosomal Storage Diseases: Results and Lessons Learned
Current Gene Therapy How Drugs Influencing Central Blood Pressure Prevent Atherosclerosis Complications?
Current Pharmaceutical Biotechnology Oxidized Haemoglobin–Driven Endothelial Dysfunction and Immune Cell Activation: Novel Therapeutic Targets for Atherosclerosis
Current Medicinal Chemistry Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Small Molecule Antagonists of Integrin Receptors
Current Medicinal Chemistry Research Progress in Competitive Purine Antagonists
Current Medicinal Chemistry Propranolol as a Model Drug to Treat Smoking Cessation and its Formulation as a Transdermal Patch for Effective Management
Letters in Drug Design & Discovery Long Chain Omega-3 Polyunsaturated Fatty Acids in Pediatric Metabolic Syndrome
Mini-Reviews in Medicinal Chemistry Bio-Antioxidants – A Chemical Base of Their Antioxidant Activity and Beneficial Effect on Human Health
Current Medicinal Chemistry Epidemiology of Vitamin D and Colorectal Cancer
Anti-Cancer Agents in Medicinal Chemistry Essential Oils with Microbicidal and Antibiofilm Activity
Current Pharmaceutical Biotechnology Antioxidative Activity, Polyphenolic Content and Anti-Glycation Effect of Some Thai Medicinal Plants Traditionally Used in Diabetic Patients
Medicinal Chemistry From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology A Systematic Review of Digital and Computer-Based Alcohol Intervention Programs in Primary Care
Current Drug Abuse Reviews An Automated Method for Detecting the Scar Tissue in the Left Ventricular Endocardial Wall Using Deep Learning Approach
Current Medical Imaging